A number of PDE4-selective inhibitors are under development specifically for CNS indications, including depression and as enhancers of learning and memory [9,10,11,12,45,46,47,48,57,58,59,60,61,62,63]. The gene discussed is PDE4A; the disease is depressive symptom measurement.